Bookmark

Add to MyYahoo RSS

Actos, Pioglitazone News

News on Actos, Pioglitazone (generic) continually updated from thousands of sources around the net.

Wednesday | Medical News

Ema CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics for VipidiaTM and the fixed-dose combination therapies VipdometTM and IncresyncTM .

Comment?

Related Topix: Medicine, Metformin (generic), Glucophage, Diabetes, Health, Glucotrol, Glipizide (generic), Opinion

Fri Jul 25, 2014

jdsupra.com

The Ghosts of Litigation Holds Past

Earlier this year, in the widely followed In re: Actos Products Liability Litigation matter, a Louisiana federal jury ordered a drug manufacturer to pay $6 billion in punitive damages and $1.5 million in actual damages.

Comment?

Related Topix: Medicine

Wed Jul 16, 2014

P&T Community

Diabetes Drug Pioglitazone May Lower Risk of Alzheimer's Disease

According to a report from Reuters, a new German study has suggested that treatment with the diabetes drug pioglitazone may reduce the risk of developing Alzheimer's disease , although conclusive proof could be years away.

Comment?

Related Topix: Medicine, Diabetes, Health, Alzheimer's, Genetics

Mon Jul 14, 2014

AlertNet

German database study hints diabetes drug cuts Alzheimer's risk

A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer's disease, although conclusive proof from a more formal trial could be about five years away.

Comment?

Related Topix: Alzheimer's, Health, Diabetes

Thu Jul 10, 2014

BioSpace

Takeda Pharmaceutical Co. Ltd. And Zinfandel Pharmaceuticals Inc. To ...

Takeda Pharmaceutical Company Limited and its partner, Zinfandel Pharmaceuticals, Inc. , will present data during multiple poster and oral sessions at the upcoming Alzheimer's Association International ConferenceA 2014 , taking place in "Studies show that individuals with mild cognitive impairmenta slight, although noticeable and measurable decline ... (more)

Comment?

Related Topix: Takeda Pharmaceutical Company, Millennium Pharmaceuticals, Pharmaceuticals, Medicine

•••
•••
•••
•••
•••
•••
•••